Built for the increasing complexity of CNS clinical development, the latest release enhances precision, scales image data processing, and strengthens data quality oversight across global trials
The study discovered that over 40,000 of the 70,000+ participants taking a GLP-1 drug, like Ozempic, quit within one year, and 42% of the participants stopped within nine months
Do you see what we mean when we say that human data is limited
Your healthcare provider should discuss realistic timelines, cost of long-term therapy, behavioral prerequisites, and whether your metabolic profile supports discontinuation goals
Hydration strategies for managing GLP-1related nausea focus on maintaining fluid balance while avoiding large-volume intake during meals that can increase gastric fullness
Blood sugar considerations Growth hormone releasing peptides can affect blood sugar regulation